Cognex Corporation CGNX
58.66
0.96
1.66%
as of 25 Sep
- Market cap
- $9.8B
- P/E
- 55.9×
Follow CGNX
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
68.64 | 52.14 | 56.97 | 68.97 |
P/S ratio |
7.82 | 6.08 | 7.79 | 11.13 | |
P/FCF ratio |
37.39 | 25.95 | 34.37 | 45.81 | |
P/Operating CF |
86.91 | 80.72 | 180.90 | 175.25 | |
P/B ratio |
5.10 | 4.05 | 5.52 | 7.44 | |
Price to Tangible BV |
7.52 | 5.90 | 7.93 | 10.24 | |
EV/Sales |
7.52 | 5.74 | 7.51 | 10.76 | |
EV/EBITDA |
38.66 | 29.64 | 34.83 | 43.93 | |
EV/Operating CF |
32.89 | 23.26 | 31.43 | 42.35 | |
EV/FCF |
35.92 | 24.50 | 33.12 | 44.29 | |
Quick Ratio |
2.69 | 2.64 | 2.47 | 2.87 | |
Current Ratio |
3.96 | 3.80 | 3.64 | 3.93 | |
Net Debt/EBITDA |
(4.63) | (7.96) | (4.42) | (4.38) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.48 | 0.50 | 0.53 | 0.52 | |
Operating CF/Net income |
4.95 | 2.29 | 0.87 | 0.95 | |
Capex/Depreciation |
(0.20) | 0.58 | (0.38) | (0.22) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
12.67% | 14.29% | 13.79% | 11.12% | |
Selling, General and Administrative Expense of Revenue |
34.11% | 37.48% | 35.03% | 30.17% | |
Intangible Assets out of Total Assets |
0.24 | 0.23 | 0.22 | 0.20 | |
Share Based Compensation of Revenue |
4.48% | 5.50% | 4.45% | 3.85% | |
Graham Net Nets |
0.02 | 0.03 | 0.02 | 0.02 | |
Graham Number |
11.48 | 11.74 | 13.11 | 15.17 | |
Earnings Yield |
1.46% | 1.92% | 1.76% | 1.45% | |
Free Cash Flow Yield |
2.67% | 3.85% | 2.91% | 2.18% | |
Revenue per Share |
1.65 | 1.50 | 1.61 | 1.74 | |
Operating CF per Share |
0.52 | 0.45 | 0.27 | 0.41 | |
Capex per Share |
(0.01) | 0.02 | (0.02) | (0.01) | |
Free Cash Flow per Share |
0.51 | 0.47 | 0.25 | 0.40 | |
Cash per Share |
1.79 | 2.01 | 1.78 | 2.42 | |
Shareholders Equity per Share |
8.88 | 8.88 | 8.88 | 9.74 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.88 | 8.88 | 8.88 | 9.74 | |
Free Cash Flow |
86.03 | 79.01 | 42.34 | 67.62 | |
Working Capital |
501.65 | 513.70 | 500.86 | 633.85 | |
Capital Expenditures |
(1.45) | 4.11 | (2.76) | (1.53) | |
Net Current Asset Value |
157.81 | 172.59 | 163.70 | 300.79 | |
EV/EBIT |
46.18 | 35.12 | 40.04 | 49.13 | |
Capex to Sales |
0.01 | (0.02) | 0.01 | 0.01 | |
Net Profit Margin |
6.38% | 12.94% | 19.26% | 24.98% | |
Price to Operating Income |
48.08 | 37.19 | 41.55 | 50.83 | |
| Other line items | |||||
Average Receivables |
156.29 | 145.04 | 165.95 | 200.09 | |
Average Payables |
37.73 | 44.12 | 51.43 | 53.67 | |
Average Inventory |
149.48 | 147.71 | 143.83 | 143.71 | |
Average Assets |
2,033.00 | 2,004.70 | 1,969.06 | 2,091.10 | |
Average Common Equity |
1,528.33 | 1,504.70 | 1,462.30 | 1,567.81 |
Columns are period end dates